Actively Recruiting

Age: 18Years - 90Years
All Genders
NCT07418242

Prognostic Value of Novel Biomarkers on Adverse Renal Outcomes in High-Risk Cardiac Surgery Patients

Led by Guowei Tu · Updated on 2026-02-24

1491

Participants Needed

2

Research Sites

170 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This project aims to detect novel biomarkers from preoperative and early postoperative serum and urine samples of patients to screen and analyze the risk factors for predicting adverse postoperative renal outcomes in high-risk patients in cardiac surgery.

CONDITIONS

Official Title

Prognostic Value of Novel Biomarkers on Adverse Renal Outcomes in High-Risk Cardiac Surgery Patients

Who Can Participate

Age: 18Years - 90Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults scheduled for elective open chest cardiac surgery
  • Patients undergoing surgery with cardiopulmonary bypass (CPB) must have at least one AKI risk factor
  • Patients undergoing surgery without CPB must have at least two AKI risk factors
  • AKI risk factors include age over 70 years, estimated glomerular filtration rate (eGFR) between 30 and 60 mL/min/1.73 m2, diabetes mellitus, proteinuria, history of congestive heart failure within the past year, left ventricular ejection fraction of 40% or lower, prior cardiac surgery, combined coronary artery bypass and valve procedure, urgent procedure, or use of preoperative intra-aortic balloon pump
Not Eligible

You will not qualify if you...

  • Pre-existing chronic kidney disease with eGFR less than 30 mL/min/1.73 m2
  • Previous renal replacement therapy before cardiac surgery
  • Acute kidney injury present at screening
  • History of kidney transplant or other kidney diseases
  • Known pregnancy
  • Multiple operations during the same hospital stay
  • Being in a moribund state with an expected death within 48 hours

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 2 locations

1

Zhongshan hospital, Fudan university

Shanghai, Shanghai Municipality, China, 200030

Not Yet Recruiting

2

Zhongshan hospital

Shanghai, Shanghai Municipality, China, 200032

Actively Recruiting

Loading map...

Research Team

G

Guo wei Tu, MD

CONTACT

Y

Ying Su, MD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

0

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here

Prognostic Value of Novel Biomarkers on Adverse Renal Outcomes in High-Risk Cardiac Surgery Patients | DecenTrialz